Sensitive ASX Announcement

FDA Clearance Amplia's IND for Pancreatic Cancer Trial in US

Published: 18/01/24, 09:42am (AEST)2 pages
Amplia Therapeutics
ATX:ASXHealthcare

Recent ATX Announcements

Price Sensitive only